Sort
261,768 grants matching “gene therapy”
Mechanisms of Platelet Activity in Vascular Disease
$996,660Jeffrey S Berger · New York University School Of Medicine · R35 · FY2024 · HL
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$996,589James L Riley · University Of Pennsylvania · U19 · FY2020 · AI
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
$996,533Gautam Sudhir Ghatnekar · Xequel Bio, Inc. · R44 · FY2015 · DK
Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development
$996,494Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE
XT-101: A Novel and Potent Non-Opioid Treatment for Neuropathic Pain
$996,485Raymond A. Chavez · Xalud Therapeutics, Inc. · U44 · FY2012 · NS
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation
$996,470Timothy S McConnell · Isoplexis, Inc. · R44 · FY2019 · CA
Genome-wide chromatin modification targeting by endogenous small RNAs
$996,415Ronald P Hart · Rutgers, The State Univ Of N.J. · RC1 · FY2010 · CA
Immunomodulatory Therapy for Neuropathic Pain
$996,399Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2021 · NS
Malaria immunology
$996,334Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$996,270Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2017 · CA
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
$996,232Jennifer Joy Smith · Precyte, Inc. · R44 · FY2018 · CA
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
$996,228Jay Edward Wrobel · Fox Chase Chemical Diversity Center, Inc · R44 · FY2020 · HL
Targeting leukocyte metabolism to treat human autoimmune disease
$996,128Jay L Rothstein · Immunext, Inc. · R44 · FY2019 · AI
Metagenomic study of the human skin microbiome associated with acne
$996,085Huiying Li · University Of California Los Angeles · UH2 · FY2009 · AR
Analytical Resources Core
$996,049Nathan A Vandergrift · Duke University · P01 · FY2016 · AI
Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates
$996,038Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2020 · AI
Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections
$996,031Christopher Gerard Cooney · Akonni Biosystems, Inc. · R44 · FY2024 · AI
Laboratory of Oral Connective Tissue Biology
$996,009Martha Somerman · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR
A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL
$996,003Mark Bagnall · Phenomix Sciences, Llc · R44 · FY2024 · DK
Innate Immune Protection by Clean Genome E. coli
$995,989Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2011 · AI
PRESERVATION AND REPLACEMENT OF BETA CELLS IN IDDM
$995,944Yeshiva University · P01 · FY2002 · DK
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2016 · AI
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2015 · AI
Stalled replication fork repair in cancer predisposition and cancertherapy
$995,896Ralph Scully · Beth Israel Deaconess Medical Center · R35 · FY2023 · CA
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy
$995,814Scott Budd Winram · Cynvec, Llc · R44 · FY2016 · CA